Stockscreener 앱 받기
231.25
3.78%
-9.09
Natera Inc 주식(NTRA)의 최신 뉴스
Natera prenatal test false advertising $8.25M class action settlement explained: Are you owed money? - Claim Depot
AI-Enhanced Signatera Upgrade And NVIDIA Deal Could Be A Game Changer For Natera (NTRA) - simplywall.st
Is It Too Late To Consider Natera (NTRA) After Its Strong 1-Year Share Price Run? - simplywall.st
Natera Targets Endometrial Cancer With New Signatera Trial, Expanding Its MRD Opportunity - TipRanks
Sumitomo Mitsui Trust Group Inc. Sells 88,968 Shares of Natera, Inc. $NTRA - MarketBeat
Assessing Whether Natera (NTRA) Is Overvalued After Strong Longer Term Share Price Gains - Yahoo Finance
Natera unveils AI model to enhance cancer recurrence risk assessment By Investing.com - Investing.com Nigeria
How Investors Are Reacting To Natera (NTRA) NVIDIA-Backed Multimodal AI And Precision Diagnostics Advances - Yahoo Finance
Natera’s SCORE Study Builds Real-World Evidence for Cancer MRD Testing - TipRanks
NTRA & NVDA Partner to Improve AI Models for Precision Medicine - TradingView — Track All Markets
Natera, Inc. Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling - marketscreener.com
Natera unveils AI model to enhance cancer recurrence risk assessment - Investing.com
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling - Yahoo Finance
Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating - TipRanks
(NTRA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
JP Morgan lifts Natera, Inc. (NTRA) target on Signatera momentum - MSN
Natera’s updated prenatal test, Fetal Focus, adds Gaucher disease - Gaucher Disease News
Natera (NTRA) Joins Forces with NVIDIA to Boost AI in Precision Medicine - GuruFocus
Nvidia enters collaboration with Natera - TipRanks
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA - marketscreener.com
Natera stock rises as Canaccord maintains Buy rating on strong preliminary results - Investing.com Nigeria
Natera stock rises as Canaccord maintains Buy rating on strong preliminary results By Investing.com - Investing.com South Africa
Natera (NTRA) Reports Robust Q4 and FY 2025 Revenue Growth - GuruFocus
Natera Q4 Preliminary Revenue Rises; Shares Up Pre-Bell - marketscreener.com
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth - BioSpace
Natera Q4 prelim revenue beats on oncology tests boost - TradingView — Track All Markets
Natera Reports Preliminary Q4 2025 Results, Record Year for Oncology Testing - Intellectia AI
Breakeven On The Horizon For Natera, Inc. (NASDAQ:NTRA) - Yahoo Finance
Natera, Inc.'s (NASDAQ:NTRA) Business Is Yet to Catch Up With Its Share Price - 富途牛牛
Natera (NASDAQ:NTRA) Stock Rating Upgraded by Citigroup - MarketBeat
Market Catalysts: Is Natera Inc. stock attractive after correctionWatch List & Consistent Income Trade Ideas - Улправда
Natera (NTRA) announces publication of findings from randomized, phase III CALGB (Alliance)/SWOG 80702 study - MSN
Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research® - GlobeNewswire Inc.
Natera, Inc. $NTRA Shares Acquired by SG Americas Securities LLC - MarketBeat
How Natera ctDNA Partnership Around STELLAR-316 At Exelixis (EXEL) Has Changed Its Investment Story - Yahoo Finance
Will Natera Inc. stock outperform tech sector in 2025Insider Buying & Real-Time Stock Entry Alerts - ulpravda.ru
Can Natera Inc. stock sustain market leadership2025 AllTime Highs & Risk Controlled Stock Pick Alerts - ulpravda.ru
Is Natera Inc. stock attractive for growth ETFs2025 Top Gainers & Free High Accuracy Swing Entry Alerts - ulpravda.ru
NTRANatera Inc Latest Stock News & Market Updates - Stock Titan
Natera (NASDAQ:NTRA) Shares Down 7.6%What's Next? - MarketBeat
Will Natera Inc. stock gain from strong economyQuarterly Portfolio Report & Risk Adjusted Buy/Sell Alerts - Улправда
Can Natera Inc. stock weather global recessionJuly 2025 Momentum & Reliable Entry Point Alerts - ulpravda.ru
Can Natera Inc. stock beat analyst upgradesJuly 2025 Opening Moves & Real-Time Chart Pattern Alerts - ulpravda.ru
EXEL Collaborates With Natera for Late-Stage Colorectal Cancer Study - Finviz
Exelixis and Natera to collaborate on MRD-guided cancer trial By Investing.com - Investing.com Nigeria
Citigroup Initiates Buy Rating on Natera (NTRA) with $300 Price Target | NTRA Stock News - GuruFocus
Assessing Natera (NTRA) Valuation After Positive ALTAIR Trial Data And Expanded Fetal Focus Test Launch - simplywall.st
Medical stock hovers near buy point after 46% gain - MSN
Why Natera’s Stock Is Sliding Despite Bullish Outlook - TipRanks
Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera - CNBC
Exelixis and Natera stocks rise on colorectal cancer trial collaboration By Investing.com - Investing.com Australia
2.40%
0.74%
자본화:
|
볼륨(24시간):